Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Takeda discloses novel cephems

Feb. 5, 1997

U.S. patent for Tularik drug discovery assays

Feb. 4, 1997

Takeda's new cephems

Feb. 4, 1997

Novel formulation of aciclovir enters pivotal trials

Jan. 31, 1997

Micrologix receives broad patent coverage for peptide antibiotic production method

Jan. 31, 1997

Novel antiinfective agents from Tanabe

Jan. 31, 1997

Bayer to market Amphotec in Canada

Jan. 30, 1997

Nobel Laureate to study bacterial resistance to nisin

Jan. 30, 1997

Famvir safe and effective in HIV-infected patients with shingles

Jan. 30, 1997

Microcide reports new cephalosporin antibiotics

Jan. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...